Ahmed M Aribi, M.D.

800-826-4673
Ahmed M Aribi, M.D.
Hematologist
Clinical Expertise
  • Leukemia
Research Area
  • Hematology and Hematopoietic Cell Transplantation
  • Leukemia
Academic Appointments
  • Assistant Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation
Clinical Teams
Hematology & Hematopoietic Cell Transplantation
Leukemia

Ahmed M. Aribi, M.D., joined the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope as an assistant professor and staff physician. Before coming to City of Hope, Aribi was an instructor within MD Anderson’s Department of Leukemia, Division of Cancer Medicine. Aribi completed fellowships at University of California, Los Angeles and MD Anderson, and before that was a resident and intern at Southern University in Springfield, Ill. He received his medical degree from Alfateh University School of Medicine in Libya. He is board certified in internal medicine and holds medical licenses in both California and Texas.

Location

Education & Experience

Board Certifications

  • Board Certified in Internal Medicine
  • ECFMG Certified
  • State of California Medical License
  • State of Texas Medical License

Degrees

  • 1996 — Alfateh University School of Medicine, Libya, M.D.

Fellowship

  • 2008-2011, Fellow, Department of Hematology, University of California Los Angeles, Los Angeles, CA
  • 2005-2007, Fellow, Department of Hematology, Leukemia, M.D. Anderson Cancer Center, Houston, TX
  • 2000-2002, Postdoctoral Fellow in Neuro-Pharmacology, Department of Pharmacology Baylor College of Medicine, Houston, TX

Residency

  • 2003-2005 Southern Illinois University, Springfield, IL

Internship

  • 1997, Internal Medicine, Alfateh University affiliated hospitals, Libya
  • 2002 -2003, Department of Internal Medicine, Southern Illinois University, Springfield, IL

Professional Experience

  • 2011-present, Assistant Professor, Hematology & Hematopoietic Cell Transplantation, City of Hope
  • 2007-2008, Instructor, Department of Leukemia, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas

Awards & Memberships

Memberships

  • American College of Physicians
  • American Medical Association

Publications

  • Ong, S. Y., Pak, S., Mei, M., Wang, Y., Popplewell, L., Baird, J. H., Herrera, A. F., Shouse, G., Nikolaenko, L., Zain, J., Godfrey, J., Htut, M., Aribi, A., Spielberger, R., Mansour, J., Forman, S. J., Palmer, J., & Budde, L. E. (2023). Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma. American journal of hematology, 10.1002/ajh.27069. Advance online publication. https://doi.org/10.1002/ajh.27069
  • Aribi, A., Salhotra, A., Afkhami, M., Munteanu, A., Ali, H., Aldoss, I., Otoukesh, S., Al Malki, M. M., Sandhu, K. S., Koller, P., Arslan, S., Stewart, F., Artz, A., Curtin, P., Ball, B., O'Hearn, J., Spielberger, R., Smith, E., Budde, E., Nakamura, R., … Pullarkat, V. (2023). WT1-mutated acute myeloid leukemia is sensitive to fludarabine-based chemotherapy and conditioning regimens. Leukemia & lymphoma, 1–11. Advance online publication. https://doi.org/10.1080/10428194.2023.2241096
  • Amanam, I., Yao, J., Puing, A., Tsai, N. C., Samuels, D., Ngo, D., Ho, S., Ali, H., Aribi, A., Arslan, S., Artz, A., Htut, M., Koller, P., Salhotra, A., Sandhu, K., Nikolaenko, L., Pawlowska, A., Shouse, G., Stein, A., Marcucci, G., … Al Malki, M. M. (2023). Use of monoclonal antibody therapy in hematologic patients with mild-to-moderate COVID-19: A retrospective single-center experience. Cancer medicine, 12(10), 11248–11253. https://doi.org/10.1002/cam4.5832
  • Ngo, D., Chen, J., Tinajero, J., Aribi, A., Arslan, S., Marcucci, G., Nakamura, R., Al Malki, M. M., Forman, S. J., Dadwal, S., & Ali, H. (2023). The impact of SARS-CoV2 vaccines on the incidence of graft versus host disease in allogeneic hematopoietic stem cell transplant recipients: a single-center retrospective study. Stem cell research & therapy, 14(1), 95. https://doi.org/10.1186/s13287-023-03326-3
  • La Rosa, C., Chiuppesi, F., Park, Y., Zhou, Q., Yang, D., Gendzekhadze, K., Ly, M., Li, J., Kaltcheva, T., Ortega Francisco, S., Gutierrez, M. A., Ali, H., Otoukesh, S., Amanam, I., Salhotra, A., Pullarkat, V. A., Aldoss, I., Rosenzweig, M., Aribi, A. M., Stein, A. S., … Diamond, D. J. (2023). Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study. Frontiers in immunology, 14, 1114131. https://doi.org/10.3389/fimmu.2023.1114131
  • Aldoss, I., Afkhami, M., Yang, D., Gu, Z., Mokhtari, S., Shahani, S., Pourhassan, H., Agrawal, V., Koller, P., Arslan, S., Tomasian, V., Al Malki, M. M., Artz, A., Salhotra, A., Ali, H., Aribi, A., Sandhu, K. S., Ball, B., Otoukesh, S., Amanam, I., … Pullarkat, V. (2023). High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions. American journal of hematology, 98(6), 848–856. https://doi.org/10.1002/ajh.26908
  • Agrawal, V., Pourhassan, H., Tsai, N. C., Ngo, D., Koller, P., Malki, M. M. A., Salhotra, A., Ali, H., Aribi, A., Sandhu, K. S., Arslan, S., Ball, B., Otoukesh, S., Amanam, I., Artz, A., Singh, D., Becker, P. S., Stewart, F. M., Smith, E. P., Curtin, P., … Aldoss, I. (2023). Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation Inotuzumab. Transplantation and cellular therapy, 29(5), 314–320. https://doi.org/10.1016/j.jtct.2023.01.017
  • Al Malki, M. M., Palmer, J., Tsai, N. C., Mokhtari, S., Hui, S., Tsai, W., Aldoss, I., Ali, H., Aribi, A., Cao, T., Mei, M., Sandhu, K. S., Siddiqi, T., Forman, S. J., Nakamura, R., Marcucci, G., Stein, A., Wong, J. Y. C., & Rosenthal, J. (2022). Total marrow and lymphoid irradiation as conditioning in haploidentical transplant with posttransplant cyclophosphamide. Blood advances, 6(14), 4098–4106. https://doi.org/10.1182/bloodadvances.2022007264
  • Aldoss, I., Yang, D., Tomasian, V., Mokhtari, S., Jackson, R., Gu, Z., Telatar, M., Yew, H., Al Malki, M. M., Salhotra, A., Khaled, S., Ali, H., Aribi, A., Sandhu, K. S., Mei, M., Arslan, S., Koller, P., Artz, A., Aoun, P., Gu, D., … Afkhami, M. (2022). Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL. Blood advances, 6(17), 4936–4948. https://doi.org/10.1182/bloodadvances.2022007597

Ratings & Reviews

Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with five stars being the highest.
4.9
Show respect for what you say
4.8
Provider explain in way you understand
4.8
Spend enough time with you
4.8
Rate provider 0-10
4.7
Recommend this provider office
4.7
Provider listen carefully to you
4.6
Know important info medical history
01/30/25
I feel that City of Hope hires only the best staff who care about the patients, which is rare to other facilities. As a cancer patient, I understand the importance in getting the right treatment from a facility that really takes the time to understand my case and help me through my journey. I will always recommend and push others who are seeking cancer treatment to transfer to the City of Hope campus to get the best treatment. My team at City of Hope saved my life. - Verified patient
01/30/25
Dr. Aribi has always been clear and transparent about my treatment options, as well as side effects and possible outcomes due to treatment. He genuinely cares about his patients and their success in recovering from their illness. - Verified patient
12/29/24
I couldn't ask for better. - Verified patient
10/28/24
Doctor Aribi Always addressed any questions I had. Always was so upbeat and my mom was always glad to see him. She always felt that she was in good hands with the doctor. - Verified patient
10/28/24
City Of Hope has come along ways since my dad had treatment back in [...]. Just in the last couple of weeks, I told two of my friends that are dealing with cancer. Look into the City Of Hope because the first diagnosis from my mothers medical group was not good, but the City Of Hope has given us a greater outlook on life ahead. - Verified patient